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enomics, proteomics, and metab-
olomics have all vastly advanced
our understanding of human biology and
disease. But the functioning of even a
simple system such as a single yeast cell or
bacterium is much more complicated
than the sum of its genes or proteins or
metabolites; it’s the activity of all those
components and their relationships to
one another that add up to a living organ-
ism. Recognizing that complexity, the
emerging field of systems biology
attempts to harness the power of mathe-
matics, engineering, and computer sci-
ence to analyze and integrate data from all
the “omics” and ultimately create working
models of entire biological systems.
“Traditionally, scientists—toxicologists
included—have relied on a reductionist
approach to biology,” says William Suk,
director of the NIEHS Center for Risk and
Integrated Sciences. Even now, many stud-
ies examine complex systems by looking at
cellular components in isolation. For
instance, a common experiment involves
using DNA microarrays to observe the
effect of a chemical exposure on thousands
of genes at once. This technique can
quickly tell a scientist which genes may be
vulnerable to that exposure. But a systems
biology approach would attempt to model
not only the chemical’s effect on gene
expression but also how that expression
will affect protein function, and in turn
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The Big Picturehow the exposure will affect cell signaling.
“There’s nothing wrong with what we’ve
been doing,” Suk says. “But systems biol-
ogy is going to take it to another level.”
Building a New Science
From one perspective, systems biology is
nothing new. At the turn of the twentieth
century, physiologists such as Walter B.
Cannon were developing the concept of
homeostasis—the self-regulatory mecha-
nisms, hunger and thirst for example, that
a living organism uses to keep its internal
systems in balance despite an ever-changing
external environment. The term “systems
biology” was first used in the 1960s, when
theoretical biologists began creating com-
puter-run mathematical models of biolog-
ical systems. 
But the field took a leap forward begin-
ning in the 1990s, when the high-through-
put tools developed for the sequencing of
the human genome brought experimental
scientists up to the speed of theoretical biol-
ogists. The widespread use of the Internet
has also made possible for the first time the
international collaborations and sharing of
huge amounts of data that systems biology
requires. “The way that computer science
has responded to genomics is one of the
great stories of the sociology of twentieth-
century science,” says Charles DeLisi, senior
associate provost for bioscience and chair of
the Bioinformatics Program at Boston
University. Computer scientists have taken a
great interest in biology and have stepped
up to collaborate with biologists to develop
the tools needed to sequence genomes and
analyze the resulting data.
Leroy Hood, a biochemist who is pres-
ident and cofounder of the nonprofit
Institute for Systems Biology, agrees.
“What uniquely defines the systems biol-
ogy that I’m thinking about has really
come from the genome project and its
delineation of a complete parts list of all
the genes,” he says. “If you know all the
genes, you have the ability to do DNA
arrays, follow the behavior of all the mes-
senger RNAs, and even the proteins, in
principle.” 
Measuring gene expression is one
important component of systems biology,
and methods for doing so are fairly well
developed for the needs of this field.
However, proteomics—the science of ana-
lyzing all the proteins present in a system
at any one time—still has some maturing
to do before scientists can integrate its
data payload into a true systems approach.
Proteomics has been hailed as having even
more potential than genomics, because
whereas DNA is a set of static instructions
for an organism, proteins—the machines
that actually carry out the work—are a
more fluid medium and may reflect the
effects of chemical exposure more accu-
rately. But to integrate protein expression
into systems biology, scientists need to
better understand its relationship to gene
expression. DeLisi says scientists still don’t
understand why in many cases there is a
tight correlation between gene and pro-
tein expression, while in others (as with
transcription factors) the correlation is
very loose. “That [understanding] will
develop over the next five to ten years,” he
predicts. 
Other researchers have pointed to the
need for more quantitative techniques to
not only detect the presence of proteins
but also determine their size, purity, and
concentration in a system. Hood agrees
that to achieve truly global analyses of
complex biological systems, proteomics
technology needs more development.
“The big problem that proteomics has is
that proteins that are expressed at very low
levels are generally invisible to the analyt-
ic techniques we have,” he says. Hood
suggests the answer to that problem lies in
highly miniaturized sensors and detectors
developed through nanotechnology and
microfluidics.
Another “omics” that promises to fill
in gaps in systems biology models is
metabolomics—the evaluation of tissues
and biofluids such as urine, blood plasma,
and saliva for metabolite changes that may
result from environmental exposures or
from disease. Because metabolites (which
include carbohydrates, amino acids, and
lipids) are the actual by-products of pro-
cessing food into energy, this “omics” has
the potential to paint a picture of what
has actually happened in the cell. 
Work in metabolomics seeks to go
beyond sampling single metabolites to
developing profiles of four or five related
metabolites. But to create meaningful
metabolite profiles, scientists need better
tools for measuring tiny amounts of
metabolites and for determining which
are most important in the activity of the
cell. Existing analytical tools such as
nuclear magnetic resonance spectrometry
and mass spectrometry go only so far.
Indeed, the Metabolomics Technology
Development initiative of the NIH
Roadmap for Medical Research encour-
ages projects that develop new methods
for measuring metabolites that are present
only in low concentrations or at specific
subcellular locations. 
The Measure Is in the Models
For those working on a systems biology
approach, the goal of developing these
various “omics” technologies is to com-
bine their data into interactive models.
Hood says, “The ultimate object of sys-
tems biology is to understand how the
elements and their interactions together
give rise to the emergent properties of the
system.” 
To do that, scientists begin by model-
ing individual components such as pro-
tein networks and signal transduction
pathways. Initially, says Hood, the models
are descriptive. They may involve perhaps
a relatively simple equation showing rela-
tionships between a few proteins in a cell.
As more information comes to light, the
models become more graphical. A graphi-
cal model may visualize a cell as a very
complicated flow chart, as a series of pin-
wheels, or as a spiderweb. Relationships
between elements are depicted through
color or distance. 
Next, researchers can experiment with
an actual system such as yeast to see what
will happen at the organism level when
one component of the system is perturbed.
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“You can do genetic perturbations where
you knock out genes, for example, or envi-
ronmental perturbations where you give
or take away certain kind of sugars,” Hood
says. “And then you observe how all the
other elements behave in response to those
perturbations.” Those experiments will
usually yield data that aren’t explained by
the model. “So you formulate hypotheses
to explain the discrepancies, and you go
back and do more of these global and inte-
grated experiments,” Hood says. 
It’s a long way from modeling yeast to
modeling a human being. But Hood
believes that the knowledge gained from a
model of a simple system can be scaled up.
Such comparative genomics—the ability
to learn about complex systems by model-
ing simpler systems that have similar
genetics—is one of the most powerful
tools in systems biology, Hood says. “The
basic idea is that once evolution latches on
to a good idea, it generally uses it over and
over again,” he says. “But when you do
these comparisons you have to be very
aware that although the very basic strate-
gy may be similar, there might be many
elaborations.” So scientists must look for
“control elements,” small elements such as
binding sites for transcription factors that
are conserved in both organisms.
The next step in modeling is to
describe relationships mathematically.
The Institute for Systems Biology has cre-
ated a mathematical model of the relative-
ly simple metabolic process by which yeast
cells get energy by breaking down the
sugar galactose. After defining all the
genes in the yeast genome and the partic-
ular genes, proteins, and other small mol-
ecules that are known to play a role in the
galactose metabolism pathway, the
researchers created a model. Then they
grew, in the presence of galactose and
without, normal yeast as well as strains
that had particular genes deleted. They
analyzed the reactions using microarrays,
quantitative proteomics, and databases of
known physical interactions. “We can
write down a series of differential equa-
tions, and we can choose parameters to
put into those differential equations and
can predict a lot of the behavior of the sys-
tem,” Hood says. 
Some scientists believe that current
bioinformatics capabilities can handle
many biological modeling tasks if a com-
plex system is portrayed as a series of
smaller models that overlap one another.
But the experimental design must inte-
grate all the “omics” from the beginning.
“The phrase ‘data integration’ has been
closely associated with buying big main-
frames and having engineers design big
databases,” says Eric Neumann, global
head of knowledge management at
Aventis Pharmaceuticals. All of this com-
putational power is aimed at trying to
combine information from experiments
that don’t have an integrated design—for
instance, trying to relate gene expression
data from one study to protein data col-
lected in a separate study.
Neumann says this integration can be
done better for one-tenth of the cost by
adopting good experimental design and
focusing more on the downstream.
Neumann’s ideal experiment involves col-
lecting gene microarray data, protein lev-
els, metabolite levels, clinical phenotypes,
and serum biomarkers in one experiment.
“If one compares across experiments, then
unless everything is kept constant, the
data may not be statistically equivalent,”
he says. “Some high-level comparisons
may be made if one accepts the independ-
ent interpretations from both studies, but
these will often be more qualitative merg-
ings than quantitative in nature.”
The integrated experiment design that
Neumann favors would allow statistically
valid merging, he says. That merging can
be accomplished with several simple data-
bases that all point to the same experimen-
tal design. The end result is a relational
database that “looks like a big spiderweb,”
Neumann says.
John Doyle, a professor of control and
dynamical systems at the California
Institute of Technology, has likened the
complexity of a biological system to that
of a Boeing 777 jet. Each system needs
only a small portion of its control systems
for basic functioning (for instance,
Escherichia coli can survive in the laborato-
ry even when 90% of its genes are
knocked out). The jet includes more than
100,000 components such as computers
and sensors, most of which are not needed
under ideal conditions, but which enable
the plane to stabilize if conditions sudden-
ly change. Likewise, biological organisms
include complex control systems that kick
in only during potential threats—such as
variations in temperature or nutrients—to
keep the organism stable. 
In general, this complexity makes the
organism robust. But some scientists
hypothesize that such complexity can
leave a system vulnerable to unplanned
disruptions such as genetic mutation. The
mutation may be tiny, but because the
gene is involved in such a complex, mul-
tilayered control network, the tiny muta-
tion can trigger a “cascading failure”—a
kind of domino effect that leads to a
major threat such as cancer or autoim-
mune disease. Mathematicians and engi-
neers are at work on algorithms and other
tools to better model this robust yet frag-
ile nature and other aspects of complex
biological systems. 
High Hopes for Tiny Tools
Some researchers say that developments in
nanotechnology and microfluidics may
revolutionize systems biology. Nanotech-
nology involves manipulating molecules
smaller than 100 nanometers—the scale of
viruses. Microfluidics, which is commonly
used in ink-jet printing, uses pumps and
valves to transport nanoliter volumes of
fluids through microchannnels in a tiny
glass or plastic chip. Hood says that nan-
otechnology and microfluidics will even-
tually enable scientists to make many dif-
ferent measurements in parallel and in
small amounts of material. “In principle,
you can make these measurements down
to the single-molecule level,” he says.
In theory, researchers could create
nanobiosensors no bigger than 100
nanometers that could be surgically
implanted into the body or injected into
the bloodstream to measure biomarkers
Focus | Systems Biology
The ultimate object of systems
biology is to understand how the
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properties of the system.
— Leroy Hoodof environmental exposure or diagnose
problems in cell function. Suk says
nanobiosensors could potentially measure
processes as sensitive as the flux of calci-
um ions inside a cell.
David Walt, a professor of chemistry at
Tufts University, is using fiber optic tech-
nology to develop tiny sensors that could be
used to screen toxicants. Optical fibers are
extremely fine strands of glass that can
transmit light to and from a sample. Right
now the sensors directly measure chemical
changes in arrays of yeast or E. coli cells in
response to toxicants such as mercury or the
chemotherapeutic agent mitomycin C. The
cells are fluorescently labeled, and the
researchers monitor chemical changes by
correlating those changes to changes in flu-
orescent intensity. 
“The goal is to be able to measure
solutions and determine their toxic poten-
tial,” Walt says. A similar method could
eventually be used to quickly screen
potential toxicants, replacing some animal
testing. First, though, studies would need
to be run to ensure that the cell-based
arrays consistently yield the same results
as animal testing, Walt says. 
Suk is excited about the idea that nano-
biosensors could enter cells and make
direct measurements of their inner work-
ings. “That will allow us to have a better
understanding—maybe even a complete
understanding for certain types of tis-
sues—of how cells and systems communi-
cate with each other,” he says. “If you can
understand how a cell works, you can then
scale up to tissues, then organs.” He pre-
dicts that nanobiosensors will make it
much easier to measure human exposures
in as soon as five years. 
A Surprising Challenge
Once all the measurements are made, what
must happen to make the megamodels of
systems biology a reality? Surprisingly
perhaps, some of the players in the field
say that the biggest challenge for systems
biology isn’t technical—rather, it’s a mat-
ter of community. 
One problem is the lack of a common
language for systems biology. As with
other multidisciplinary collaborations, all
the players will need to develop a lan-
guage they can share. That became
apparent at a December 2003 retreat on
systems biology that Suk organized for
the NIEHS Division of Extramural
Research and Training, where speakers
included an engineer, a biochemist, a
computer scientist, and a physician—
each of whom approaches the field from
his or her own perspective. 
Neumann agrees the biggest chal-
lenges for systems biology are human
ones—language and data sharing.
“There’s a side to it that involves data
analysis by people who feel comfortable
looking at data, writing programs, some
numerics,” he says. But that analysis
needs interpretation from scientists who
know about disease and about environ-
mental exposures. 
Neumann believes that getting the rel-
evant data to those who can interpret it is
the biggest bottleneck for the field. “There
are more papers than ever before in science,
and most of us can’t read them all,” he says.
Simple text queries such as those used to
search literature databases capture words or
phrases out of context. But it’s possible
now, Neumann says, to populate scientific
papers with embedded, machine-readable
phrases that convey the relevance of the
work. Such databases would use ontolo-
gies—formal, machine-readable defini-
tions of terms and the relationships
between those terms. Programs that know
something about logic and relationships
can help weed out irrelevant information,
Neumann says, and help reveal connec-
tions between concepts. 
In the 2004 Proceedings of the Pacific
Symposium on Biocomputing, Daniel
McShan of the University of Colorado
and colleagues present an example of
how such data mining can be used to
predict the behavior of a biopathway.
The team developed an algorithm to
extract, or infer, biotransformation rules
from the Kyoto Encyclopedia of Genes
and Genomes (KEGG), a web-accessible
database of pathways, genes, and gene
expressions. Using KEGG, the team
inferred 110 biotransformation rules
about what happens when certain com-
pounds interact. They used these rules as
well as mathematical algorithms to pre-
dict how detoxification pathways would
metabolize ethyl and furfuryl alcohol.
The model’s prediction correlated with
known patterns of alcohol metabolism. 
Automated data mining tools are well
on their way to development now.
“Vendors are working on various applica-
tions that would support the enhanced
linking of documents anywhere, and
eighty to ninety percent of that [technol-
ogy] already exists,” Neumann says. [For
an example of one such tool, see
“Literature Searchlight,” EHP 112:A872
(2004).]
The real test is how willing scientists
are to use these tools. “We already take
enough time footnoting our papers.
Imagine if those footnotes were machine-
readable,” Neumann says. Authors would
use software that works like a spell-
checker to screen their papers and choose
the formal concepts that are most rele-
vant. “So all of a sudden the whole search
and review of literature changes over-
night,” he says. “Right now we all are
doing text mining and extraction by our-
selves. But in the future it will be done by
authors as they submit their papers.” 
Neumann believes that PubMed
Central and other efforts to make all fed-
erally funded research freely available will
provide an opening for data mining to
become commonplace. “To survive, the
scientific publishers are going to have to
ask, ‘What’s our added value?’ If added
value can be putting [text] in a smart
ontology—bingo. I think we will see
quick embracement of this so that [scien-
tific publishers] find a whole new market
strategy,” he says.
DeLisi adds that more emphasis on
computational and mathematical train-
ing for scientists will help make systems
biology more mainstream. “Most of us in
this area now have educated ourselves,”
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he says. “People end up learning what
they need to learn to solve the problems
they’re interested in solving.” 
Several training programs in bioin-
formatics and systems biology exist,
such as the one that DeLisi is involved
in at Boston University and those at var-
ious University of California campuses.
Other programs are under development.
“I’m very optimistic,” DeLisi says.
“Over the next ten to fifteen years I
expect to see a very large shift toward a
much more mathematical biology, and
certainly toward a highly computation-
ally intensive biology. I have no doubt
that in the next ten to twenty years, biol-
ogy will be the most computational of
all the sciences.”
Optimistic Predictions
Suk’s biggest hope for systems biology is
that it will create more realistic models of
complex environmental exposures. “We’re
exposed to lots of chemicals but at very
low concentrations over time,” he says.
“We need tools to help us understand
how complex exposures perturb complex
systems.” 
Such tools to help elucidate system
interrelationships are forthcoming. For
example, in the August 2004 toxico-
genomics issue of EHP, Hiroyoshi Toyo-
shiba and colleagues at the NIEHS
Laboratory of Computational Biology
and Risk Analysis reported the creation
of a statistical software program that
quantitatively sorts gene expression data
to identify which genes interact in a net-
work. The team has used the program to
determine the effect of the carcinogen
tetrachlorodibenzo-p-dioxin on 11 genes
in lung epithelial cells and the genes’ sub-
sequent effect on the retinoic acid signal
transduction pathway. 
This program looks further than com-
paring a simple pair of genes. Instead it
shows the relationships between a whole
set of genes in a network. The study
authors have said that when the tool is
expanded to include other data such as
protein levels, it will help researchers
understand biopathways in cells, tissues,
and eventually entire organisms.
David Schwartz, a professor of medi-
cine and genetics at Duke University,
acknowledges the benefit of the systems
biology approach but tempers his enthu-
siasm with a focus on the here and now.
“Systems biology may help us under-
stand biological processes, but we have
to put them into a context of human
disease,” he says. Schwartz’s lab investi-
gates how gene expression profiles can
be used as preclinical markers to help
understand the biology and genetics of
complex environmentally related dis-
eases such as asthma. “We can also use
global ‘omic’ approaches to identify bio-
logic pathways that are specifically
affected by disease-based environmental
toxicants,” he says.
But Suk is optimistic that systems
biology will deliver on its promise for
environmental health in the near future.
“We’re only limited by two things—by
our ability to [grasp] it and by money,”
he says. 
A working model of an entire biolog-
ical system would possess enormous
power for learning how environmental
exposures result in disease. And some sci-
entists say that many elements of such a
model are within science’s grasp. 
But fully embracing the systems
approach will also require scientists to
embrace change. They must create a new
language for the field. They must design
experiments always with the whole sys-
tem in mind. They must even learn a
new way of footnoting their papers.
How will all this change happen? Like
the intricate webs of systems biology
models themselves, the answer is sure to
be complex.
Angela Spivey
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